Email

cmchong@um.edu.mo

Tel

(853) 8822-4512

Office

N22-7014

Consultation Hours

Tue: 16:30-17:30
Thu: 16:30-17:30

Cheong Meng CHONG 鍾昌明

Assistant Professor

Academic Qualifications

  • Postdoctoral training, National University of Singapore, Singapore
  • Ph.D., University of Macau, Macau

Teaching

CMED8003Functional Food Product Development in Chinese Medicine
CMED7009Development of Drugs and Health Product
HSCI3000Neuroscience and Neurodegenerative Diseases

Research Interests

  1. Understanding the molecular basis of cellular pathology in neurodegenerative diseases.
  2. Identifying the bioactive components from traditional Chinese medicine (TCM) for treatment of neurodegenerative diseases.
  3. Functional TCM-derived food products development.

We are looking for Ph.D. students and master students who are interested in neuropharmacology. For further information, please contact Dr. Chong via email (cmchong@um.edu.mo).

  1. Chong CM, Zhong Z, Vong CT, Wang S, Lu JJ, Zhong HJ, Su H, Wang Y. The potentials of Uncariae Ramulus Cum Uncis for treatment of migraine: Targeting CGRP in the trigeminovascular system. Current Neuropharmacology. 2021. (IF: 7.363).
  2. Ke M*, Chong CM*, Zhu Qi, Zhang K, Cai CZ, Lu J, Qin D, Su H. Comprehensive perspectives on experimental models for Parkinson’s disease. Aging and Disease. 2020. (IF: 6.745) (Co-first author).
  3. Ke M*, Chong CM*, Zeng H, Huang M, Huang Z, Zhang K, Cen X, Lu J, Yao X, Qin D, Su H. Azoramide protects iPSC-derived dopaminergic neurons with PLA2G6 D331Y mutation through restoring ER function and CREB signaling. Cell Death and Disease. 2020.11(2):130. (IF: 8.469) (Co-first author).
  1. Ke M*, Chong CM*, Su H. Using induced pluripotent stem cells for modeling Parkinson’s disease. World Journal of Stem Cells. 2019. 11(9):634-649. (IF: 5.326) (co-first author).
  2. Chong CM, Su H, Lu JJ, Wang Y. The neuroprotective effects of bioactive components from rhizome of Salvia miltiorrhiza (Danshen) on Alzheimer’s disease. Chinese Medicine. 2019. 14:19. (IF: 5.455).
  3. Chong CM, Ke M, Tan Y, Huang Z, Zhang Z, Ai N, Ge W, Qin D, Lu JH, Su H. Presenilin 1 deficiency suppresses autophagy in human neural stem cells through reducing γ-secretase-independent ERK/CREB signaling. Cell Death and Disease. 2018. 9(9):879. (IF: 8.469).
  4. Chong CM, Ai N, Ke M, Tan Y, Huang Z, Lu JH, Ge W, Su H. Roles of nitric oxide synthase isoforms in neurogenesis. Mol Neurobiol. 2018. 55(3):2645-2652. (IF: 5.590).
  5. Chong CM, Ai N, Lee MY. ROCK in CNS: different roles of isoforms, and therapeutic target for neurodegenerative disorders. Current drug targets. 2017. 18(4):455-462. (IF: 3.465).
  6. Chong CM, Ma D, Zhao C, Franklin RJ, Zhou ZY, Li C, Ai N, Yu H, Hou T, Sa F, Lee MY. Discovery of a novel neuroprotectant, BHDPC that protects against MPP+-inducedneuronal death in multiple experimental models. Free radical biology and medicine. 2015.89:1057-1066 (IF: 7.376).
  7. Chong CM, Shen MG, Zhou ZY, Pan P, Hoi PM, Li S, Wang L, Ai N, Zhang LQ, Li CW, Yu HD, Hou TJ, Lee MY. Discovery of a benzofuran derivative (MBPTA) as a novel ROCK inhibitor in protecting against MPP+-induced oxidative stress and cell death in SH-SY5Y cells. Free radical biology and medicine. 2014. 74:283-93. (IF: 7.376).

  • Young Editorial Consultant of Chinese Medicine
  • Director of Macau Life Sciences Institute (MLSI)
  • The permanent member of Macau Laboratory Technologist Association (MLTA)